BR9611248A - Implantes e explantes de matriz hìbrida - Google Patents
Implantes e explantes de matriz hìbridaInfo
- Publication number
- BR9611248A BR9611248A BR9611248-4A BR9611248A BR9611248A BR 9611248 A BR9611248 A BR 9611248A BR 9611248 A BR9611248 A BR 9611248A BR 9611248 A BR9611248 A BR 9611248A
- Authority
- BR
- Brazil
- Prior art keywords
- explants
- hybrid matrix
- matrix implants
- implants
- several
- Prior art date
Links
- 239000011159 matrix material Substances 0.000 title abstract 3
- 239000007943 implant Substances 0.000 title abstract 2
- 102000008186 Collagen Human genes 0.000 abstract 2
- 108010035532 Collagen Proteins 0.000 abstract 2
- 229920001436 collagen Polymers 0.000 abstract 2
- 229920002307 Dextran Polymers 0.000 abstract 1
- 239000004793 Polystyrene Substances 0.000 abstract 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
- 235000010410 calcium alginate Nutrition 0.000 abstract 1
- 239000000648 calcium alginate Substances 0.000 abstract 1
- 229960002681 calcium alginate Drugs 0.000 abstract 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 239000011521 glass Substances 0.000 abstract 1
- 239000004816 latex Substances 0.000 abstract 1
- 229920000126 latex Polymers 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000004005 microsphere Substances 0.000 abstract 1
- 229920002492 poly(sulfone) Polymers 0.000 abstract 1
- 229920002401 polyacrylamide Polymers 0.000 abstract 1
- 229920002223 polystyrene Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/426—Immunomodulating agents, i.e. cytokines, interleukins, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/64—Animal cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Composite Materials (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Prostheses (AREA)
Abstract
Patente de Invenção: <B>"IMPLANTES E EXPLANTES DE MATRIZ HìBRIDA"<D>. Um dispositivo implantável possuindo um corpo de material de matriz constituído de fibrilas de colágeno insolúvel e dispostas dentro de: (a) várias células de vertebrados; e (b) várias microesferas cada uma das quais consistindo, primariamente, de um ou mais dos seguintes materiais: colágeno, poliestireno, dextran, poliacrilamida, celulose alginato de cálcio, látex, polissulfona ou vidro.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/548,002 US5965125A (en) | 1995-10-25 | 1995-10-25 | Hybrid matrix implants and explants |
PCT/US1996/017114 WO1997015195A1 (en) | 1995-10-25 | 1996-10-25 | Hybrid matrix implants and explants |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9611248A true BR9611248A (pt) | 1999-12-28 |
Family
ID=24187023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9611248-4A BR9611248A (pt) | 1995-10-25 | 1996-10-25 | Implantes e explantes de matriz hìbrida |
Country Status (10)
Country | Link |
---|---|
US (3) | US5965125A (pt) |
EP (1) | EP0917428A4 (pt) |
JP (1) | JP2000501299A (pt) |
CN (1) | CN1199567C (pt) |
AU (1) | AU706563B2 (pt) |
BR (1) | BR9611248A (pt) |
NO (1) | NO326107B1 (pt) |
NZ (1) | NZ321417A (pt) |
RU (1) | RU2201765C2 (pt) |
WO (1) | WO1997015195A1 (pt) |
Families Citing this family (107)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050186673A1 (en) * | 1995-02-22 | 2005-08-25 | Ed. Geistlich Soehne Ag Fuer Chemistrie Industrie | Collagen carrier of therapeutic genetic material, and method |
GB9721585D0 (en) * | 1997-10-10 | 1997-12-10 | Geistlich Soehne Ag | Chemical product |
US6528483B2 (en) | 1995-06-07 | 2003-03-04 | André Beaulieu | Method of producing concentrated non-buffered solutions of fibronectin |
US6419920B1 (en) | 1995-10-25 | 2002-07-16 | Trans Karyotic Therapies, Inc. | Hybrid matrix implants and explants |
IL118376A0 (en) * | 1996-05-22 | 1996-09-12 | Univ Ben Gurion | Polysaccharide sponges for cell culture and transplantation |
US6150164A (en) * | 1996-09-30 | 2000-11-21 | The Regents Of The University Of Michigan | Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo |
US7899511B2 (en) | 2004-07-13 | 2011-03-01 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US9155496B2 (en) | 1997-03-04 | 2015-10-13 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US20050033132A1 (en) | 1997-03-04 | 2005-02-10 | Shults Mark C. | Analyte measuring device |
US20010007673A1 (en) * | 1999-11-12 | 2001-07-12 | Merrill Seymour Goldenberg | Sustained-release delayed gels |
TW586934B (en) * | 1997-05-19 | 2004-05-11 | Sumitomo Pharma | Immunopotentiating composition |
GB9718415D0 (en) * | 1997-08-29 | 1997-11-05 | Smithkline Beecham Plc | Formulation |
US20050186283A1 (en) * | 1997-10-10 | 2005-08-25 | Ed. Geistlich Soehne Ag Fuer Chemistrie Industrie | Collagen carrier of therapeutic genetic material, and method |
US6886568B2 (en) * | 1998-04-08 | 2005-05-03 | The Johns Hopkins University | Method for fabricating cell-containing implants |
US6378527B1 (en) * | 1998-04-08 | 2002-04-30 | Chondros, Inc. | Cell-culture and polymer constructs |
US7427602B1 (en) * | 1998-05-13 | 2008-09-23 | The Regents Of The University Of Michigan | Sustained DNA delivery from structural matrices |
WO2000017328A2 (en) * | 1998-09-21 | 2000-03-30 | Isis Innovation Limited | Fibrils |
WO2000056375A2 (en) * | 1999-03-19 | 2000-09-28 | The Regents Of The University Of Michigan | Mineralization and cellular patterning on biomaterial surfaces |
US6767928B1 (en) | 1999-03-19 | 2004-07-27 | The Regents Of The University Of Michigan | Mineralization and biological modification of biomaterial surfaces |
US6662805B2 (en) * | 1999-03-24 | 2003-12-16 | The Johns Hopkins University | Method for composite cell-based implants |
US6287340B1 (en) * | 1999-05-14 | 2001-09-11 | Trustees Of Tufts College | Bioengineered anterior cruciate ligament |
US6372494B1 (en) | 1999-05-14 | 2002-04-16 | Advanced Tissue Sciences, Inc. | Methods of making conditioned cell culture medium compositions |
ATE284674T1 (de) * | 1999-10-05 | 2005-01-15 | Transkaryotic Therapies Inc | Hybride matrizen und gemische davon |
EP1099443A1 (en) | 1999-11-11 | 2001-05-16 | Sulzer Orthopedics Ltd. | Transplant/implant device and method for its production |
AU2001245513A1 (en) * | 2000-03-06 | 2001-09-17 | Kumarpal A. Shah | Method for immune switching |
US7144729B2 (en) | 2000-09-01 | 2006-12-05 | Dfb Pharmaceuticals, Inc. | Methods and compositions for tissue regeneration |
AR034262A1 (es) * | 2000-09-14 | 2004-02-18 | Transkaryotic Therapies Inc | Una composicion para proporcionar una mezcla fluida inyectable, un equipo, un metodo para preparacion de una mezcla de dicho equipo, un aparato para la introduccion de una mezcla en un paciente |
US6538010B1 (en) * | 2000-11-08 | 2003-03-25 | Research Triangle Institute | Compounds and methods for promoting smoking cessation |
US6444222B1 (en) * | 2001-05-08 | 2002-09-03 | Verigen Transplantation Services International Ag | Reinforced matrices |
CA2388723C (en) | 2001-06-06 | 2012-10-23 | Becton, Dickinson & Company | Method of providing a substrate with a ready-to-use, uniformly distributed extracellular matrix |
EP1406573A4 (en) * | 2001-06-07 | 2005-03-30 | Skinmedica Inc | CONDITIONED CELL CULTURE MEDIA AND ITS USES |
EP1416878A4 (en) * | 2001-07-16 | 2007-04-18 | Depuy Products Inc | BIOLOGICAL / SYNTHETIC BIOABSORBABLE HYBRID EQUIPMENT |
AU2002316694B2 (en) * | 2001-07-16 | 2007-09-06 | Depuy Products, Inc. | Hybrid biologic/synthetic porous extracellular matrix scaffolds |
US8337537B2 (en) * | 2001-07-16 | 2012-12-25 | Depuy Products, Inc. | Device from naturally occurring biologically derived materials |
US8012205B2 (en) * | 2001-07-16 | 2011-09-06 | Depuy Products, Inc. | Cartilage repair and regeneration device |
US6867189B2 (en) * | 2001-07-26 | 2005-03-15 | Genset S.A. | Use of adipsin/complement factor D in the treatment of metabolic related disorders |
AU2002331669A1 (en) * | 2001-08-23 | 2003-03-10 | The Wistar Institute Of Anatomy And Biology | An organotypic intestinal culture and methods of use thereof |
US7332330B2 (en) * | 2001-09-11 | 2008-02-19 | Renamed Biologics, Inc. | Device for maintaining vascularization near an implant |
US20040031067A1 (en) * | 2001-10-11 | 2004-02-12 | Meenhard Herlyn | Regulation of human skin healing |
US20030166274A1 (en) * | 2001-11-15 | 2003-09-04 | Hewitt Charles W. | Three-dimensional matrix for producing living tissue equivalents |
US6902932B2 (en) * | 2001-11-16 | 2005-06-07 | Tissue Regeneration, Inc. | Helically organized silk fibroin fiber bundles for matrices in tissue engineering |
US8858434B2 (en) | 2004-07-13 | 2014-10-14 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10022078B2 (en) | 2004-07-13 | 2018-07-17 | Dexcom, Inc. | Analyte sensor |
WO2003075790A2 (en) * | 2002-03-08 | 2003-09-18 | The University Of Texas Health Science Center At San Antonio | Gas-plasma treatment of implants |
US7442546B2 (en) * | 2002-03-15 | 2008-10-28 | The Regents Of The University Of Michigan | Method of modulating inflammatory response |
US7431922B2 (en) * | 2002-03-29 | 2008-10-07 | Tissuegene, Inc. | Bioadhesive directed somatic cell therapy |
AU2003234197A1 (en) * | 2002-04-22 | 2003-11-03 | Tufts University | Multi-dimensional strain bioreactor |
US7459152B2 (en) * | 2003-04-23 | 2008-12-02 | Rush University Medical Center | Erythropoietin administration to improve graft survival |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US7927599B2 (en) * | 2003-09-08 | 2011-04-19 | Ethicon, Inc. | Chondrocyte therapeutic delivery system |
US8257963B2 (en) * | 2007-06-01 | 2012-09-04 | Depuy Mitek, Inc. | Chondrocyte container and method of use |
US7897384B2 (en) * | 2003-09-08 | 2011-03-01 | Ethicon, Inc. | Chondrocyte therapeutic delivery system |
EP1670897A4 (en) * | 2003-09-24 | 2008-02-27 | Univ Leland Stanford Junior | IGF-1 MULTIPOTENTE ADULTS HAS NEW NEURAL CNS STEM CELLS INTO AN OLIGOD DROGLIA CELLINE |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
US8423114B2 (en) | 2006-10-04 | 2013-04-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
EP2256493B1 (en) | 2003-12-05 | 2014-02-26 | DexCom, Inc. | Calibration techniques for a continuous analyte sensor |
US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
WO2009048462A1 (en) | 2007-10-09 | 2009-04-16 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
US8808228B2 (en) | 2004-02-26 | 2014-08-19 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
ES2432556T3 (es) | 2004-08-04 | 2013-12-04 | Evonik Corporation | Métodos para fabricar dispositivos de suministro y sus dispositivos |
WO2006073514A2 (en) * | 2004-08-25 | 2006-07-13 | Tufts University | Compositions, methods and kits for repressing virulence in gram positive bacteria |
WO2006110193A2 (en) | 2005-04-08 | 2006-10-19 | Dexcom, Inc. | Cellulosic-based interference domain for an analyte sensor |
US8744546B2 (en) | 2005-05-05 | 2014-06-03 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
WO2006124770A2 (en) * | 2005-05-13 | 2006-11-23 | The Feinstein Institute For Medical Research | Treatment of sepsis and inflammation with alpha2a adrenergic antagonists |
US8921109B2 (en) | 2005-09-19 | 2014-12-30 | Histogenics Corporation | Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof |
US20070148144A1 (en) * | 2005-10-27 | 2007-06-28 | Mason James M | Gene-enhanced tissue engineering |
US9757061B2 (en) | 2006-01-17 | 2017-09-12 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US8679809B2 (en) | 2006-05-19 | 2014-03-25 | The University Of Hong Kong | Cell-matrix microspheres, methods for preparation and applications |
WO2007146319A2 (en) * | 2006-06-13 | 2007-12-21 | Symphony Medical, Inc. | Methods and apparatus for using polymer-based beads and hydrogels for cardiac applications |
KR100803576B1 (ko) | 2006-06-14 | 2008-02-15 | 주식회사 인피트론 | 지방줄기세포 및 지방세포를 포함한 이식용 조성물 |
KR20070122316A (ko) * | 2006-06-26 | 2007-12-31 | (주) 에스바이오메딕스 | 주사용 인체 연조직 충전제 및 이의 제조 방법 |
KR20070122315A (ko) * | 2006-06-26 | 2007-12-31 | (주) 에스바이오메딕스 | 자가 진피 세포 및 히알루론산을 함유하는 주사용 인체연조직 충전제 조성물 |
US8735154B2 (en) * | 2006-10-30 | 2014-05-27 | The University Of Kansas | Templated islet cells and small islet cell clusters for diabetes treatment |
WO2008154312A1 (en) | 2007-06-08 | 2008-12-18 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
EP2175978B1 (en) * | 2007-07-06 | 2019-02-20 | The University of Hong Kong | Collagen-based microspheres and methods of preparation and use thereof |
KR100956267B1 (ko) * | 2007-12-12 | 2010-05-07 | 주식회사 에이프로테크놀로지 | 엘라스틴을 안정화제로서 함유하는 반유동성 이식용 조성물 |
WO2009078022A2 (en) * | 2007-12-17 | 2009-06-25 | Izun Pharmaceuticals Corporation | Synergistic combinations of growth factors with herbal compositions for the enhancement of tissue repair |
US8728528B2 (en) | 2007-12-20 | 2014-05-20 | Evonik Corporation | Process for preparing microparticles having a low residual solvent volume |
US9402724B2 (en) * | 2008-05-12 | 2016-08-02 | Mo-Sci Corporation | Dynamic bioactive nanofiber scaffolding |
KR20110056323A (ko) | 2008-09-15 | 2011-05-26 | 제넨테크, 인크. | 세포 오스몰농도를 조절하기 위한 조성물 및 방법 |
US9889230B2 (en) * | 2008-10-17 | 2018-02-13 | Covidien Lp | Hemostatic implant |
US9308070B2 (en) | 2008-12-15 | 2016-04-12 | Allergan, Inc. | Pliable silk medical device |
GB0912399D0 (en) * | 2009-07-16 | 2009-08-26 | Ucl Business Plc | Polymeric collagen biomaterials |
RU2449799C2 (ru) * | 2009-10-30 | 2012-05-10 | Федеральное Государственное Учреждение "Российский кардиологический научно-производственный комплекс Федерального агентства по высокотехнологичной медицинской помощи" | Средство для осуществления терапевтического ангиогенеза и способ его осуществления |
WO2011113446A1 (en) * | 2010-03-17 | 2011-09-22 | Amsilk Gmbh | Method for production of polypeptide containing fibres |
US8597948B2 (en) | 2011-03-10 | 2013-12-03 | First Principles, Inc. | Cloned biological material medical device and method thereof |
US20140378661A1 (en) * | 2011-04-20 | 2014-12-25 | Trustees Of Tufts College | Molded regenerated silk geometries using temperature control and mechanical processing |
KR101327630B1 (ko) * | 2012-03-05 | 2013-11-13 | 울산대학교 산학협력단 | 아텔로콜라겐을 이용한 췌도세포 이식용 담체의 제조방법 그리고 이를 이용하여 제조된 인공췌장 |
KR102618557B1 (ko) * | 2013-05-08 | 2023-12-28 | 인리젠 | 단리된 신장 세포를 포함하는 오가노이드 및 이의 용도 |
KR102390107B1 (ko) | 2013-05-30 | 2022-04-25 | 그라함 에이치. 크리시 | 국부 신경 자극 |
US11229789B2 (en) | 2013-05-30 | 2022-01-25 | Neurostim Oab, Inc. | Neuro activator with controller |
US10077420B2 (en) | 2014-12-02 | 2018-09-18 | Histogenics Corporation | Cell and tissue culture container |
US9238090B1 (en) | 2014-12-24 | 2016-01-19 | Fettech, Llc | Tissue-based compositions |
US11077301B2 (en) | 2015-02-21 | 2021-08-03 | NeurostimOAB, Inc. | Topical nerve stimulator and sensor for bladder control |
US10973956B2 (en) | 2017-01-05 | 2021-04-13 | The Regents Of The University Of Michigan | Microporous hydrogel scaffolds for cell transplantation |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
WO2019083939A1 (en) | 2017-10-24 | 2019-05-02 | Dexcom, Inc. | PRECONNECTED ANALYTE SENSORS |
KR102562469B1 (ko) | 2017-11-07 | 2023-08-01 | 뉴로스팀 오에이비, 인크. | 적응형 회로를 구비한 비침습성 신경 활성화기 |
CN111787907A (zh) * | 2018-02-22 | 2020-10-16 | 维多利亚大学工业合作股份有限公司 | 释放形态发生化合物的微球及其在生物墨水中的应用 |
CN108690205A (zh) * | 2018-05-28 | 2018-10-23 | 深圳市第二人民医院 | 一种ⅱ型胶原和聚丙烯酰胺复合水凝胶及其制备和应用 |
RU2722744C1 (ru) * | 2019-03-26 | 2020-06-03 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр реабилитации и курортологии" Министерства здравоохранения Российской Федерации (ФГБУ НМИЦ РК Минздрава России) | Органоспецифический биопластический материал на основе растворимой формы стабилизированного внеклеточного матрикса |
CN114126704A (zh) | 2019-06-26 | 2022-03-01 | 神经科学技术有限责任公司 | 具有自适应电路的非侵入性神经激活器 |
JP2023506713A (ja) | 2019-12-16 | 2023-02-20 | ニューロスティム テクノロジーズ エルエルシー | 昇圧電荷送達を用いた非侵襲性神経アクティベータ |
CN111203115B (zh) * | 2020-01-07 | 2022-02-11 | 天津市第三中心医院 | 一种氧化多糖抗凝涂层血液透析膜材料及其制备方法 |
WO2021210026A1 (en) * | 2020-04-17 | 2021-10-21 | Vasanthi Palanivel | A cell-free growth factor concentrate, method of preparing the same and a kit thereof |
CN115785256A (zh) * | 2022-11-09 | 2023-03-14 | 武汉轻工大学 | 一种调控胶原与细胞受体结合能力的方法 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2967509D1 (en) * | 1978-12-26 | 1985-10-10 | Massachusetts Inst Technology | Skin-equivalent |
US4485096A (en) * | 1982-02-26 | 1984-11-27 | Massachusetts Institute Of Technology | Tissue-equivalent and method for preparation thereof |
US4686098A (en) * | 1984-05-14 | 1987-08-11 | Merck & Co., Inc. | Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone DNA, and a method of administering BGH in vivo |
US4604346A (en) * | 1984-10-09 | 1986-08-05 | Massachusetts Institute Of Technology | Skin-equivalent prepared by the use of punch biopsy |
US4863856A (en) * | 1985-04-04 | 1989-09-05 | Verax Corporation | Weighted collagen microsponge for immobilizing bioactive materials |
US4861714A (en) * | 1985-04-04 | 1989-08-29 | Verax Corporation | Weighted collagen microsponge for immobilizing bioactive material |
US4997753A (en) * | 1985-04-04 | 1991-03-05 | Verax Corporation | Weighted collagen microsponge for immobilizing bioactive material |
US5100783A (en) * | 1985-05-10 | 1992-03-31 | Verax Corporation | Weighted microsponge for immobilizing bioactive material |
US5032508A (en) * | 1988-09-08 | 1991-07-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US4963489A (en) * | 1987-04-14 | 1990-10-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US5266480A (en) * | 1986-04-18 | 1993-11-30 | Advanced Tissue Sciences, Inc. | Three-dimensional skin culture system |
EP0338716A3 (en) * | 1988-04-21 | 1990-04-11 | Berlex Laboratories, Inc. | Method and system for the production of non-degraded proteins from mammalian cells |
US4837379A (en) * | 1988-06-02 | 1989-06-06 | Organogenesis Inc. | Fibrin-collagen tissue equivalents and methods for preparation thereof |
IL90690A0 (en) * | 1988-09-30 | 1990-01-18 | Organogenesis Inc | Tissue equivalents and their preparation |
US5106949A (en) * | 1989-09-15 | 1992-04-21 | Organogenesis, Inc. | Collagen compositions and methods for preparation thereof |
IL95429A (en) * | 1989-09-15 | 1997-09-30 | Organogenesis | Living tissue equivalents comprising hydrated collagen lattice and a collagen gel and their production |
US5032550A (en) | 1989-10-13 | 1991-07-16 | Aluminum Company Of America | High impact resistant ceramic composite |
US5256418A (en) * | 1990-04-06 | 1993-10-26 | Organogenesis, Inc. | Collagen constructs |
US5270192A (en) * | 1991-02-07 | 1993-12-14 | Monsanto Company | Biological artificial liver |
PT101031B (pt) * | 1991-11-05 | 2002-07-31 | Transkaryotic Therapies Inc | Processo para o fornecimento de proteinas por terapia genetica |
BR9307455A (pt) * | 1992-11-16 | 1999-06-01 | Univ Brown Res Found | Macrocápsula processos de terapia celular e de determinação a retentividade viral de uma camisa externa de uma macrocápsula permeavelmente seletiva |
TW402639B (en) * | 1992-12-03 | 2000-08-21 | Transkaryotic Therapies Inc | Protein production and protein delivery |
EP0702723B1 (fr) * | 1993-04-21 | 2002-09-04 | Institut Pasteur | Implant biocompatible pour l'expression et la secretion in vivo d'un compose therapeutique |
FR2704236B1 (fr) * | 1993-04-21 | 1995-06-23 | Pasteur Institut | Vecteur rétroviral pour la préparation de cellules recombinantes susceptibles d'être implantées in vivo dans un but thérapeutique. |
FR2708202B1 (fr) * | 1993-07-26 | 1996-03-29 | Pasteur Institut | Implant biocompatible pour l'expression chez l'homme ou chez l'animal de substances déterminées. |
ATE275194T1 (de) * | 1994-01-13 | 2004-09-15 | Rogosin Inst | Makroeingekapselte sekretorische zellen |
EP0754065A1 (en) * | 1994-04-04 | 1997-01-22 | Collagen Corporation | Cell-gels |
-
1995
- 1995-10-25 US US08/548,002 patent/US5965125A/en not_active Expired - Fee Related
-
1996
- 1996-10-25 EP EP96936960A patent/EP0917428A4/en not_active Withdrawn
- 1996-10-25 BR BR9611248-4A patent/BR9611248A/pt not_active Application Discontinuation
- 1996-10-25 JP JP9516803A patent/JP2000501299A/ja active Pending
- 1996-10-25 AU AU74744/96A patent/AU706563B2/en not_active Ceased
- 1996-10-25 NZ NZ321417A patent/NZ321417A/xx unknown
- 1996-10-25 CN CNB961993243A patent/CN1199567C/zh not_active Expired - Fee Related
- 1996-10-25 RU RU98109891/14A patent/RU2201765C2/ru not_active IP Right Cessation
- 1996-10-25 WO PCT/US1996/017114 patent/WO1997015195A1/en not_active Application Discontinuation
-
1998
- 1998-04-24 NO NO19981859A patent/NO326107B1/no not_active IP Right Cessation
-
1999
- 1999-05-14 US US09/312,246 patent/US6472181B1/en not_active Expired - Fee Related
-
2002
- 2002-07-02 US US10/188,628 patent/US6582391B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6582391B2 (en) | 2003-06-24 |
US20030077260A1 (en) | 2003-04-24 |
NO981859L (no) | 1998-06-24 |
AU706563B2 (en) | 1999-06-17 |
US6472181B1 (en) | 2002-10-29 |
NZ321417A (en) | 2000-03-27 |
CN1205613A (zh) | 1999-01-20 |
RU2201765C2 (ru) | 2003-04-10 |
CN1199567C (zh) | 2005-05-04 |
EP0917428A4 (en) | 2002-09-18 |
AU7474496A (en) | 1997-05-15 |
WO1997015195A1 (en) | 1997-05-01 |
JP2000501299A (ja) | 2000-02-08 |
US5965125A (en) | 1999-10-12 |
EP0917428A1 (en) | 1999-05-26 |
NO981859D0 (no) | 1998-04-24 |
NO326107B1 (no) | 2008-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9611248A (pt) | Implantes e explantes de matriz hìbrida | |
US4968317B1 (en) | Surgical materials and devices | |
CA2270599A1 (en) | Chemical modification of biomedical materials with genipin | |
BR9706835A (pt) | Hidrogel de copolìmero de acrilamida implantável para usos terapêuticos | |
EP0910342A4 (en) | TEMPERATURE RESPONSIBLE GEL FOR DELAYED RELEASE OF PROTEIN SUBSTANCES | |
EP0251695A3 (en) | Injectable implant composition having improved intrudability | |
BR9808609A (pt) | Sistema de construção. | |
DE59008217D1 (de) | Hydrophile quellfähige Pfropfpolymerisate, deren Herstellung und Verwendung. | |
ATE85225T1 (de) | Chirurgisches biokompositmaterial und dessen herstellung. | |
ATE158507T1 (de) | Mit gel gefüllte implantate | |
BR9610357B1 (pt) | composição sinterizada artificial bioativa, estrutura microporosa cerámica aparente, dispositivo implantável, processo para o cultivo de células de ossos funcionais e kit para monitorar e quantificar a atividade das referidas células | |
FR2747042B1 (fr) | Medicament a base de progesterone et d'oestradiol | |
FR2737659B1 (fr) | Composition cosmetique contenant une dispersion aqueuse de polymere et une silicone insoluble, utilisation et procede | |
DK124091D0 (da) | Farmaceutisk genprodukt | |
Gilbert et al. | Macromolecular release from collagen monolithic devices | |
BR9902643A (pt) | Emulsão de óleo de silicone, composição e método de fabricação | |
EP0267624A3 (en) | Porous calcium phosphate based bone prosthesis | |
DE69628162D1 (de) | Polymermaterial, medizinisches material und flüssige polymerzusammensetzung | |
BR9913285A (pt) | Método de modulação das células t efetoras da memória e composições | |
BRPI0409031A (pt) | implante helicoidal | |
DE69533455D1 (de) | Bioresorbiebares polymer für cochlear und andere implantate | |
SE8604974D0 (sv) | Beninvextkammare | |
CA2235811A1 (en) | Hybrid matrix implants and explants | |
DE69842093D1 (de) | Kortikalknochenimplantat für Wirbelfusion nach Smith-Robinson | |
ES2061024T3 (es) | Uso terapeutico de antagonistas de receptores de 5-ht3. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A E 10A ANUIDADES.. |
|
B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |